Capital Flow Monitor · Sponsors · CIK 1710088
Aeovian Pharmaceuticals, Inc.
2930 Domingo Ave., Suite 145, Berkeley, CA, 94705 · 510-961-1148
Pharmaceuticals · Corporation· inc. DELAWARE true
Fit score
—
Offering
$55.0M
Sold
$55.0M
% sold
100.0%
Investors
13
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-12-22 | D ·current | 506(b) | $55.0M | $55.0M | 100.0% | 13 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Allison J. Hulme — Executive Officer / Director, Berkeley, CA
- Micah Zajic — Executive Officer, Berkeley, CA
- William Greene — Director, Berkeley, CA
- Justin Gover — Director, Berkeley, CA
-
Richard Gaster — Director, Berkeley, CA
1 other raise
- Entact Bio, Inc. $10.0M of $10.0M · 100.0%
- Lars Ekman — Director, Berkeley, CA
-
Nils Regge — Director, Berkeley, CA
1 other raise
- Nula Therapeutics, Inc. $7.4M of $7.4M · 100.0%
-
Themasap Khan — Director, Berkeley, CA
2 other raises
- LumaBio I LP $410.0M of —
- Integrated Biosciences, Inc. $68.4M of $100.0M · 68.4%
- Youssef Bennani — Director, Berkeley, CA
- John Kincaid — Executive Officer, Berkeley, CA
- Davis Ryman — Executive Officer, Berkeley, CA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.